This grant will support the ongoing and future efforts of the Investigational Therapeutics Program at Doernbecher Children’s Hospital, OHSU. The time and effort required to maintain a high-quality Phase I program is considerable. Paramount to such a program is an infrastructure that ensures the safe and ethical conduct of these studies. Our Division of Pediatric Oncology is an active member of the Children’s Oncology Group (COG) Phase I Consortium and has enrolled over 30 patients onto investigational studies in the past three years.

Doernbecher Children’s Hospital Foundation
3181 SW Sam Jackson Park Rd.
Portland, OR 97239
United States